OMAPATRILAT (4S,7S,10aS)-4-((S)-2-巯基-3-苯基丙酰氨基)-5-氧代八氢-2H-吡啶并[2,1-B][1,3]硫杂氮杂-7-甲酸

CAS 167305-00-2 MFCD00935634

化学结构图

167305-00-2
SMILES: OC(=O)[C@@H]1CCC[C@@H]2SCC[C@H](NC(=O)[C@@H](S)CC3C=CC=CC=3)C(=O)N12

化学属性

Mol. FormulaC19H24N2O4S2
Mol. Weight408.541

别名和识别编码

Chemical NameOMAPATRILAT
Chemical Name Translation(4S,7S,10aS)-4-((S)-2-巯基-3-苯基丙酰氨基)-5-氧代八氢-2H-吡啶并[2,1-B][1,3]硫杂氮杂-7-甲酸
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Robl JA, et al. Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics asinhibitors of angiotensin-converting enzyme and neutral endopeptidase. J Med Chem. 1997 May 23;40(11):1570-7.
  • [3]. Ichiki T, et al. Endothelial permeability in vitro and in vivo: protective actions of ANP and omapatrilat in experimental atherosclerosis. Peptides. 2013 Oct;48:21-6.
  • [4]. Burrell LM, et al. Antihypertensive and antihypertrophic effects of omapatrilat in SHR. Am J Hypertens. 2000 Oct;13(10):1110-6.
  • [1]. Fryer RM, et al. Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy ofenzymes associated with bradykinin-mediated angioedema.Br J Pharmacol. 2008 Mar;153(5):947-55.
  • [1]. Fryer RM, et al. Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy ofenzymes associated with bradykinin-mediated angioedema.Br J Pharmacol. 2008 Mar;153(5):947-55.
  • [2

系列性分类


相关产品推荐